High-throughput profiling of the humoral immune responses against thirteen human papillomavirus types by proteome microarrays

Virology

Volumn 405, Issue 1, 2010, Pages 31-40

  Luevano, Martha ^a   Bernard, Hans Ulrich ^b   Barrera Saldaña, Hugo A ^a   Trevino, Victor ^c   Garcia Carranca, Alejandro ^d   Villa, Luisa L ^e   Monk, Bradley J ^f   Tan, Xiaolin ^f   Davies, D Huw ^f   Felgner, Phil L ^f   Kalantari, Mina ^b  

^a Medicina UANL   (Mexico)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c SCHOOL OF ENGINEERING AND SCIENCES   (Mexico)

^d UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

^e LUDWIG INSTITUTE FOR CANCER RESEARCH   (Brazil)

^f UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Cervical cancer; E7; High throughput; Humoral immuneresponse; Microarray; Papillomavirus; Serology

Indexed keywords

MONOCLONAL ANTIBODY; PROTEIN E4; PROTEIN E5; UNCLASSIFIED DRUG; VIRUS PROTEIN;

ARTICLE; CONDYLOMA ACUMINATUM; CONTROLLED STUDY; CROSS REACTION; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 1; HUMAN PAPILLOMAVIRUS TYPE 11; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; HUMAN PAPILLOMAVIRUS TYPE 2; HUMAN PAPILLOMAVIRUS TYPE 31; HUMAN PAPILLOMAVIRUS TYPE 35; HUMAN PAPILLOMAVIRUS TYPE 4; HUMAN PAPILLOMAVIRUS TYPE 45; HUMAN PAPILLOMAVIRUS TYPE 53; HUMAN PAPILLOMAVIRUS TYPE 6; HUMORAL IMMUNITY; IMMUNE RESPONSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN MICROARRAY; PROTEOMICS; SEROPREVALENCE; WART VIRUS;

HUMAN PAPILLOMAVIRUS; HUMAN PAPILLOMAVIRUS TYPES; PAPILLOMAVIRIDAE;

EID: 77955514666     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2010.05.011     Document Type: Article

References (45)

1. Baker C.C., Calef C. Maps of papillomavirus transcripts. Human Papillomaviruses 1995 Compendium 1995, 3-19. Los Alamos National Laboratory, Los Alamos, NM, part III-A. G. Myers, H.U. Bernard, H. Delius, C.C. Baker, J. Icenogle, A. Halpern, C. Wheeler (Eds.).
2. Baldi P., Hatfield G.W. DNA microarrays and gene expression. Experiments to Data Analysis and Modeling 2002, Cambridge University Press.
3. Baldi P., Long A.D. A Bayesian framework for the analysis of microarray expression data: regularized t-test and statistical inferences of gene changes. Bioinformatics 2001, 17:509-519.
4. Barbour A.G., Jasinskas A., Kayala M.A., Davies D.H., Steere A.C., Baldi P., Felgner P.L. A genome-wide proteome array reveals a limited set of immunogens in natural infections of humans and white-footed mice with Borrelia burgdorferi. Infect. Immun. 2008, 76:3374-3389.
5. Beare P.A., Chen C., Bouman T., Pablo J., Unal B., Cockrell D.C., Brown W.C., Barbian K.D., Porcella S.F., Samuel J.E., Felgner P.L., Heinzen R.A. Candidate antigens for Q fever serodiagnosis revealed by immunoscreening of a Coxiella burnetii protein microarray. Clin. Vaccine Immunol. 2008, 15:1771-1779.
6. Benjamini Y., Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J. R. Stat. Soc. B 1995, 57:289-300.
7. Bernard H.U., Burk R.D., Chen Z., van Doorslaer K., zur Hausen H., de Villiers E.M. Classification of papillomaviruses based on 189 PV types and proposal of taxonomic amendments. Virology 2010, publ. by electronic publication.
8. Boxman I.L., Mulder L.H., Russell A., Bouwes-Bavinck J.N., Green A., Ter Schegget J. Human papillomavirus type 5 is commonly present in immunosuppressed and immunocompetent individuals. Br. J. Dermatol. 1999, 141:246-249.
9. Davies D.H., Liang X., Hernandez J.E., Randall A., Hirst S., Mu Y., Romero K.M., Nguyen T.T., Kalantari-Dehaghi M., Crotty S., Baldi P., Villarreal L.P., Felgner P.L. Profiling the humoral immune response to infection by using proteome microarrays: high-throughput vaccine and diagnostic antigen discovery. Proc. Natl. Acad. Sci. U. S. A. 2005, 102:547-552.
10. Davies D.H., McCausland M.M., Valdez C., Huynh D., Hernandez J.E., Mu Y., Hirst S., Villarreal L., Felgner P.L., Crotty S. Vaccinia virus H3L envelope protein is a major target of neutralizing antibodies in humans and elicits protection against lethal challenge in mice. J. Virol. 2005, 79:11724-11733.
11. Davies D.H., Wyatt L.S., Newman F.K., Earl P.L., Chun W., Hernandez J.E., Molina D.M., Hirst S., Moss B., Frey S.E., Felgner P.L. Antibody profiling by proteome microarray reveals the immunogenicity of the attenuated smallpox vaccine modified vaccinia virus ankara is comparable to that of Dryvax. J. Virol. 2008, 82:652-663.
12. de Gruijl T.D., Bontkes H.J., Walboomers J.M., Schille J.T., Stukart M.J., Groot B.S., Chabaut M.M., Remmink A.J., Verheijen R.H., Helmerhorst T.J., Meijer C.J., Scheper R.J. Immunoglobulin G responses against human papillomavirus type 16 virus-like particles in a prospective nonintervention cohort study of women with cervical intraepithelial neoplasia. J. Natl. Cancer Inst. 1997, 89:630-638.
13. de Villiers E.M., Fauquet C., Broker T.R., Bernard H.U., zur Hausen H. Classification of papillomaviruses. Virology 2004, 324:17-27.
14. DiBonito P., Grasso F., Mochi S., Accardi L., Dona M.G., Branca M., Costa S., Mariani L., Agarossi A., Ciotti M., Syrjänen K., Giorgi C. Serum antibody response to human papillomavirus (HPV) infections detected by a novel ELISA technique based on denatured recombinant HPV16 L1, L2, E4, E6 and E7 proteins. Infect. Agent. Cancer 2006, 8:1-6.
15. Doolan D.L., Mu Y., Unal B., Sundaresh S., Hirst S., Valdez C., Randall A., Molina D., Liang X., Freilich D.A., Oloo J.A., Blair P.L., Aguiar J.C., Baldi P., Davies D.H., Felgner P.L. Profiling humoral immune responses to P. falciparum infection with protein microarrays. Proteomics 2008, 8:4680-4694.
16. Durbin B.P., Hardin J.S., Hawkins D.M., Rocke D.M. A variance-stabilizing transformation for gene-expression microarray data. Bioinformatics 2002, 18(Suppl 1):S105-S110.
17. Egelkrout E.M., Galloway D.A. The humoral immune response to human papillomavirus. The Papillomaviruses 2007, 277-312. Springer Science, New York. R.L. Garcea, D. DiMaio (Eds.).
18. Felgner P.L., Kayala M.A., Vigil A., Burk C., Nakajima-Sasaki R., Pablo J., Molina D.M., Hirst S., Chew J.S., Wang D., Tan G., Duffield M., Yang R., Neel J., Chantratita N., Bancroft G., Lertmemongkolchai G., Davies D.H., Baldi P., Peacock S., Titball R.W. A Burkholderia pseudomallei protein microarray reveals serodiagnostic and cross-reactive antigens. Proc. Natl. Acad. Sci. U. S. A. 2009, 106:13499-13504.
19. Huber W., von Heydebreck A., Sültmann H., Poustka A., Vingron M. Variance stabilization applied to microarray data calibration and to the quantification of differential expression. Bioinformatics 2002, 18(Suppl 1):S96-S104.
20. Jeong N.H., Woo M.K., Lee N.W., Hur S.J., Choi K.S., Kim H.J. Human papillomavirus 16 and 18 L1 serology in Korean women with high-grade cervical intraepithelial neoplasia and cervical cancer. Arch. Pharm. Res. 2009, 32:1013-1018.
21. Kreil D.P., Karp N.A., Lilley K.S. DNA microarray normalization methods can remove bias from differential protein expression analysis of 2D difference gel electrophoresis results. Bioinformatics 2004, 20:2026-2034.
22. Lehtinen M., Pawlita M., Zumbach K., Lie K., Hakama M., Jellum E., Koskela P., Luostarinen T., Paavonen J., Pukkala E., Sigstad E., Thoresen S., Dillner J. Evaluation of antibody response to human papillomavirus early proteins in women in whom cervical cancer developed 1 to 20 years later. Am. J. Obstet. Gynecol. 2003, 188:49-55.
23. Long A.D., Mangalam H.J., Chan B.Y., Tolleri L., Hatfield G.W., Baldi P. Improved statistical inference from DNA microarray data using analysis of variance and a Bayesian statistical framework. Analysis of global gene expression in Escherichia coli K12. J. Biol. Chem. 2001, 276:19937-19944.
24. McLaughlin-Drubin M.E., Münger K. The human papillomavirus E7 oncoprotein. Virology 2009, 384:335-344.
25. McLean C.S., Churcher M.J., Meinke J., Smith G.L., Higgins G., Stanley M., Minson A.C. Production and characterisation of a monoclonal antibody to human papillomavirus type 16 using recombinant vaccinia virus. J. Clin. Pathol. 1990, 43:488-492.
26. Meschede W., Zumbach K., Braspenning J., Scheffner M., Benitez-Bribiesca L., Luande J., Gissmann L., Pawlita M. Antibodies against early proteins of human papillomaviruses as diagnostic markers for invasive cervical cancer. J. Clin. Microbiol. 1998, 36:475-480.
27. Munoz N., Bosch F.X., de Sanjosé S., Herrero R., Castellsagué X., Shah K.V., Snijders P.J.F., Meijer C.J.L.M. Epidemiological classification of human papillomavirus types associated with cervical cancer. N. Engl. J. Med. 2003, 348:518-527.
28. Human Papillomaviruses 1994. A Compilation and Analysis of Nucleic Acid and Amino Acid Sequences 1994, Los Alamos National Laboratory, Los Alamos, NM, USA. G. Myers, H.U. Bernard, H. Delius, M. Favre, J. Icenogel, M. van Ranst, C. Wheeler (Eds.).
29. Ravaggi A., Romani C., Pasinetti B., Tassi R., Bignotti E., Bandiera E., Odicino F.E., Ragnoli M., Donzelli C., Falchetti M., Calza S., Santin A.D., Pecorelli S. Correlation between serological immune response analyzed by a new ELISA for HPV-16/18 E7 oncoprotein and clinical characteristics of cervical cancer patients. Arch. Virol. 2006, 151:1899-1916.
30. Reuschenbach M., Waterboer T., Wallin K.L., Einenkel J., Dillner J., Hamsikova E., Eschenbach D., Zimmer H., Heilig B., Kopitz J., Pawlita M., Knebel Doeberitz M., Wentzensen N. Characterization of humoral immune responses against p16, p53, HPV16 E6 and HPV16 E7 in patients with HPV-associated cancers. Int. J. Cancer 2008, 123:2626-2631.
31. Reuschenbach M., von Knebel Doeberitz M., Wentzensen N. A systematic review of humoral immune responses against tumor antigens. Cancer Immunol. Immunother. 2009, 58:1535-1544.
32. Rosales R., López-Contreras M., Cortes R.R. Antibodies against human papillomavirus (HPV) type 16 and 18 E2, E6 and E7 proteins in sera: correlation with presence of papillomavirus DNA. J. Med. Virol. 2001, 65:736-644.
33. Silins I., Avall-Lundqvist E., Tadesse A., Jansen K.U., Stendahl U., Lenner P., Zumbach K., Pawlita M., Dillner J., Frankendal B. Evaluation of antibodies to human papillomavirus as prognostic markers in cervical cancer patients. Gynecol. Oncol. 2002, 85:333-338.
34. Smith E.M., Ritchie J.M., Pawlita M., Rubenstein L.M., Haugen T.H., Turek L.P., Hamsikova E. Human papillomavirus seropositivity and risks of head and neck cancer. Int. J. Cancer 2007, 120:825-832.
35. Stanley M. Antibody reactivity to HPV E6 and E7 oncoproteins and early diagnosis of invasive cervical cancer. Am. J. Obstet. Gynecol. 2003, 188:3-4.
36. Steger G., Olszewsky M., Stockfleth E., Pfister H. Prevalence of antibodies to human papillomavirus type 8 in human sera. J. Virol. 1990, 64:4399-4406.
37. Suchánková A., Ritterová L., Krcmár M., Krchnák V., Vágner J., Jochmus I., Gissmann L., Kanka J., Vonka V. Comparison of ELISA and Western blotting for human papillomavirus type 16 E7 antibody determination. J. Gen. Virol. 1991, 10:2577-2581.
38. Sundaresh S., Doolan D.L., Hirst S., Mu Y., Unal B., Davies D.H., Felgner P.L., Baldi P. Identification of humoral immune responses in protein microarrays using DNA microarray data analysis techniques. Bioinformatics 2006, 22:1760-1766.
39. Sundaresh S., Randall A., Unal B., Petersen J.M., Belisle J.T., Hartley M.G., Duffield M., Titball R.W., Davies D.H., Felgner P.L., Baldi P. From protein microarrays to diagnostic antigen discovery: a study of the pathogen Francisella tularensis. Bioinformatics 2007, 23:i508-i518.
40. Villa L.L., Ault K.A., Giuliano A.R., Costa R.L., Petta C.A., Andrade R.P., Brown D.R., Ferenczy A., Harper D.M., Koutsky L.A., Kurman R.J., Lehtinen M., Malm C., Olsson S.E., Ronnett B.M., Skjeldestad F.E., Steinwall M., Stoler M.H., Wheeler C.M., Taddeo F.J., Yu J., Lupinacci L., Railkar R., Marchese R., Esser M.T., Bryan J., Jansen K.U., Sings H.L., Tamms G.M., Saah A.J., Barr E. Immunologic responses following administration of a vaccine targeting human papillomavirus types 6, 11, 16, and 18. Vaccine 2006, 24:5571-5583.
41. Viscidi R.P., Sun Y., Tsuzaki B., Bosch F.X., Muñoz N., Shah K.V. Serologic response in human papillomavirus-associated invasive cervical cancer. Int. J. Cancer 1993, 55:780-784.
42. Wang S.S., Schiffman M., Herrero R., Carreon J., Hildesheim A., Rodriguez A.C., Bratti M.C., Sherman M.E., Morales J., Guillen D., Alfaro M., Clayman B., Burk R.D., Viscidi R.P. Determinants of human papillomavirus 16 serological conversion and persistence in a population-based cohort of 10 000 women in Costa Rica. Br. J. Cancer 2004, 91:1269-1274.
43. Waterboer T., Sehr P., Michael K.M., Franceschi S., Nieland J.D., Joos T.O., Templin M.F., Pawlita M. Multiplex human papillomavirus serology based on in situ-purified glutathione S-transferase fusion proteins. Clin. Chem. 2005, 51:1845-1853.
44. Waterboer T., Neale R., Michael K.M., Sehr P., de Koning M.N., Weissenborn S.J., Sampogna F., Abeni D., Green A.C., Bouwes Bavinck J.N., Pawlita M. Antibody responses to 26 skin human papillomavirus types in the Netherlands, Italy and Australia. J. Gen. Virol. 2009, 90:1986-1998.
45. zur Hausen H. Papillomaviruses and cancer: from basic studies to clinical application. Nat. Rev. Cancer 2002, 2:342-350.